| Nome |
# |
|
Immunomodulatory effect of ibrutinib: Reducing the barrier against fungal infections, file e31e124e-7a62-987f-e053-3705fe0a095a
|
501
|
|
Multiparametric flow cytometry for MRD monitoring in hematologic malignancies: Clinical applications and new challenges, file e31e1250-805a-987f-e053-3705fe0a095a
|
429
|
|
Association between molecular lesions and specific B-cell receptor subsets in chronic lymphocytic leukemia, file e31e124b-4996-987f-e053-3705fe0a095a
|
294
|
|
Lenalidomide in Pretreated Mantle Cell Lymphoma Patients: An Italian Observational Multicenter Retrospective Study in Daily Clinical Practice (the Lenamant Study), file e31e124d-8e98-987f-e053-3705fe0a095a
|
283
|
|
Characterization of Specific Immune Responses to Different Aspergillus Antigens during the Course of Invasive Aspergillosis in Hematologic Patients, file e31e124d-7e57-987f-e053-3705fe0a095a
|
247
|
|
The coding genome of splenic marginal zone lymphoma: activation of NOTCH2 and other pathways regulating marginal zone development, file e31e124a-d87a-987f-e053-3705fe0a095a
|
241
|
|
Integrated mutational and cytogenetic analysis identifies new prognostic subgroups in chronic lymphocytic leukemia, file e31e124b-4994-987f-e053-3705fe0a095a
|
235
|
|
Lenalidomide interferes with tumor-promoting properties of nurse-like cells in chronic lymphocytic leukemia, file e31e124b-4f22-987f-e053-3705fe0a095a
|
226
|
|
Efficacy of bendamustine and rituximab as first salvage treatment in chronic lymphocytic leukemia and indirect comparison with ibrutinib: A GIMEMA, ERIC and UK CLL FORUM study, file e31e124d-8c3b-987f-e053-3705fe0a095a
|
221
|
|
Managing chronic myeloid leukemia for treatment-free remission: a proposal from the GIMEMA CML WP, file e31e124d-debc-987f-e053-3705fe0a095a
|
208
|
|
Chlorambucil plus rituximab as front-line therapy for elderly and/or unfit chronic lymphocytic leukemia patients: Correlation with biologically-based risk stratification, file e31e124d-85ff-987f-e053-3705fe0a095a
|
204
|
|
Analysis of the chronic lymphocytic leukemia coding genome: role of NOTCH1 mutational activation, file e31e124b-31af-987f-e053-3705fe0a095a
|
202
|
|
Pathogenetic mechanisms of hepatitis C virus-induced B-cell lymphomagenesis., file e31e124a-a4f7-987f-e053-3705fe0a095a
|
194
|
|
NOTCH1 mutations in +12 chronic lymphocytic leukemia (CLL) confer an unfavorable prognosis, induce a distinctive transcriptional profiling and refine the intermediate prognosis of +12 CLL, file e31e124e-0073-987f-e053-3705fe0a095a
|
189
|
|
Targeting neoplastic B cells and harnessing microenvironment: the “double face” of ibrutinib and idelalisib, file e31e124b-4b25-987f-e053-3705fe0a095a
|
188
|
|
Idelalisib impairs T-cell-mediated immunity in chronic lymphocytic leukemia, file e31e124d-7e49-987f-e053-3705fe0a095a
|
187
|
|
Endothelin-1 promotes survival and chemoresistance in chronic lymphocytic leukemia B cells through eta receptor, file e31e124b-4d61-987f-e053-3705fe0a095a
|
184
|
|
Development of hypogammaglobulinemia in patients treated with imatinib for chronic myeloid leukemia or gastrointestinal stromal tumor, file e31e124d-ed40-987f-e053-3705fe0a095a
|
172
|
|
Sensitive detection of circulating breast cancer cells by reverse-transcriptase polymerase chain reaction of maspin gene, file e31e124c-4bb7-987f-e053-3705fe0a095a
|
170
|
|
Tumor evolutionary directed graphs and the history of chronic lymphocytic leukemia, file e31e124b-4b1a-987f-e053-3705fe0a095a
|
157
|
|
Characterization and dynamics of specific T cells against nucleophosmin-1 (NPM1)-mutated peptides in patients with NPM1-mutated acute myeloid leukemia, file e31e124d-e69c-987f-e053-3705fe0a095a
|
152
|
|
Inflammatory microenvironment and specific t cells in myeloproliferative neoplasms: Immunopathogenesis and novel immunotherapies, file e31e1250-9d8b-987f-e053-3705fe0a095a
|
149
|
|
First report of FIP1L1-PDGFRα-positive eosinophilic granulomatosis with polyangiitis, file e31e124b-fa83-987f-e053-3705fe0a095a
|
147
|
|
Age and organ damage correlate with poor survival in myeloma patients: meta-analysis of 1435 individual patient data from 4 randomized trials, file e31e124a-ea64-987f-e053-3705fe0a095a
|
144
|
|
Minimal/Measurable Residual Disease Monitoring in NPM1-Mutated Acute Myeloid Leukemia: A Clinical Viewpoint and Perspectives, file e31e124d-7e4b-987f-e053-3705fe0a095a
|
143
|
|
Italian real life experience with ibrutinib: Results of a large observational study on 77 relapsed/refractory mantle cell lymphoma, file e31e124d-8c3a-987f-e053-3705fe0a095a
|
140
|
|
The PI3-kinase delta inhibitor idelalisib (GS-1101) targets integrin-mediated adhesion of chronic lymphocytic leukemia (CLL) cell to endothelial and marrow stromal cells, file e31e124a-dd25-987f-e053-3705fe0a095a
|
138
|
|
The role of molecular monitoring in autotransplantation for non-Hodgkin's lymphoma, file e31e124c-3ac8-987f-e053-3705fe0a095a
|
137
|
|
Intrinsic and extrinsic factors influencing the clinical course of B-cell chronic lymphocytic leukemia: prognostic markers with pathogenetic relevance, file e31e124e-19fe-987f-e053-3705fe0a095a
|
129
|
|
Monocytic population in chronic lymphocytic leukemia shows altered composition and deregulation of genes involved in phagocytosis and inflammation, file e31e124d-f796-987f-e053-3705fe0a095a
|
128
|
|
Multiple myeloma shows no intra-disease clustering of immunoglobulin heavy chain genes, file e31e124d-f79d-987f-e053-3705fe0a095a
|
126
|
|
Missense mutations in the PML/RAR alpha ligand binding domain in ATRA-resistant As2O3 sensitive relapsed acute promyelocytic leukemia, file e31e124e-1464-987f-e053-3705fe0a095a
|
124
|
|
Mucorales-specific T cells in patients with hematologic malignancies, file e31e124b-b2de-987f-e053-3705fe0a095a
|
120
|
|
Stereotyped patterns of B-cell receptor in splenic marginal zone lymphoma., file e31e124e-1438-987f-e053-3705fe0a095a
|
119
|
|
IGHV gene mutational status and 17p deletion are independent molecular predictors in a comprehensive clinical-biological prognostic model for overall survival prediction in chronic lymphocytic leukemia., file e31e124e-0840-987f-e053-3705fe0a095a
|
118
|
|
BCR-ABL-specific cytotoxic T cells in the bone marrow of patients with Ph(+) acute lymphoblastic leukemia during second-generation tyrosine-kinase inhibitor therapy., file e31e124e-0900-987f-e053-3705fe0a095a
|
117
|
|
Biological and clinical implications of BIRC3 mutations in chronic lymphocytic leukemia, file e31e124e-7a66-987f-e053-3705fe0a095a
|
113
|
|
Physical contact with endothelial cells through β1- and β2- integrins rescues chronic lymphocytic leukemia from spontaneous and drug-induced apoptosis and induces a peculiar gene expression profile on leukemic cells., file e31e124d-f79c-987f-e053-3705fe0a095a
|
110
|
|
The bone marrow represents an enrichment site of specific T lymphocytes against filamentous fungi, file e31e124f-08fe-987f-e053-3705fe0a095a
|
107
|
|
All-trans retinoic acid (ATRA) in non-promyelocytic acute myeloid leukemia (AML): results of combination of ATRA with low-dose Ara-C in three elderly patients with NPM1-mutated AML unfit for intensive chemotherapy and review of the literature, file e31e124c-ac63-987f-e053-3705fe0a095a
|
106
|
|
Ibrutinib modifies the function of monocyte/macrophage population in chronic lymphocytic leukemia, file e31e124f-4728-987f-e053-3705fe0a095a
|
103
|
|
Ofatumumab in poor-prognosis chronic lymphocytic leukemia: a Phase 4, non--interventional, observational study from the European Research Initiative on Chronic Lymphocytic Leukemia, file e31e124b-178c-987f-e053-3705fe0a095a
|
96
|
|
Genetic and phenotypic attributes of splenic marginal zone lymphoma, file e31e1250-a45a-987f-e053-3705fe0a095a
|
90
|
|
Neoantigen-specific T-cell immune responses: The paradigm of NPM1-mutated acute myeloid leukemia, file e31e1250-97ad-987f-e053-3705fe0a095a
|
87
|
|
Nurse-Like Cells and Chronic Lymphocytic Leukemia B Cells: A Mutualistic Crosstalk inside Tissue Microenvironments, file e31e1250-a833-987f-e053-3705fe0a095a
|
84
|
|
Macitentan, a double antagonist of endothelin receptors, efficiently impairs migration and microenvironmental survival signals in chronic lymphocytic leukemia, file e31e124e-af66-987f-e053-3705fe0a095a
|
75
|
|
Circulating functional T cells specific to human herpes virus 6 (HHV6) antigens in individuals with chromosomally integrated HHV6, file e31e124f-23c0-987f-e053-3705fe0a095a
|
73
|
|
The Krüppel-like factor 2 transcription factor gene is recurrently mutated in splenic marginal zone lymphoma, file e31e124e-f070-987f-e053-3705fe0a095a
|
66
|
|
BCR-ABL-specific T-cell therapy in Ph+ ALL patients on tyrosine-kinase inhibitors, file e31e124f-4c21-987f-e053-3705fe0a095a
|
66
|
|
Early palliative/supportive care in acute myeloid leukaemia allows low aggression end-of-life interventions: Observational outpatient study, file f26d76e4-eeb2-4b82-8342-a1799229b43f
|
65
|
|
Efficacy of Front-Line Ibrutinib and Rituximab Combination and the Impact of Treatment Discontinuation in Unfit Patients with Chronic Lymphocytic Leukemia: Results of the Gimema LLC1114 Study, file e31e1250-aaaa-987f-e053-3705fe0a095a
|
60
|
|
Efficacy of idelalisib and rituximab in relapsed/refractory chronic lymphocytic leukemia treated outside of clinical trials. A report of the Gimema Working Group, file e31e1250-8163-987f-e053-3705fe0a095a
|
56
|
|
Efficacy of imatinib mesylate as maintenance therapy in adults with acute lymphoblastic leukemia in first complete remission, file e31e124e-1e4c-987f-e053-3705fe0a095a
|
55
|
|
Antineoplastic effects of liposomal siRNA treatment targeting BLIMP1/PRDM1 in primary effusion lymphoma, file e31e124d-a1f5-987f-e053-3705fe0a095a
|
35
|
|
Indoleamine 2, 3-Dioxygenase 1 Mediates Survival Signals in Chronic Lymphocytic Leukemia via Kynurenine/Aryl Hydrocarbon Receptor-Mediated MCL1 Modulation, file e31e1250-6f46-987f-e053-3705fe0a095a
|
34
|
|
BTK Inhibitors Impair Platelet-Mediated Antifungal Activity, file e31e1250-8058-987f-e053-3705fe0a095a
|
33
|
|
An 81-Year-Old Man with a 6-Year History of Chronic Lymphocytic Leukemia Presenting with Disease Flare Following Ibrutinib Discontinuation, file 0eec5798-2a1d-4c0b-bdbe-cec308f22c8e
|
32
|
|
Randomized phase 2 study: Elotuzumab plus bortezomib/dexamethasone vs bortezomib/dexamethasone for relapsed/refractory MM, file e31e124b-cc4f-987f-e053-3705fe0a095a
|
32
|
|
BTK Inhibition Impairs the Innate Response Against Fungal Infection in Patients With Chronic Lymphocytic Leukemia, file e31e1250-874b-987f-e053-3705fe0a095a
|
28
|
|
Lenalidomide-based induction and maintenance in elderly newly diagnosed multiple myeloma patients: updated results of the EMN01 randomized trial, file e31e1250-a466-987f-e053-3705fe0a095a
|
27
|
|
Chronic lymphocytic leukemia management in Italy during the COVID-19 pandemic: A Campus CLL report, file e31e1250-7200-987f-e053-3705fe0a095a
|
25
|
|
Investigating the association between physicians self-efficacy regarding communication skills and risk of “burnout”, file e31e1250-9a84-987f-e053-3705fe0a095a
|
22
|
|
The Role of T Cell Immunity in Monoclonal Gammopathy and Multiple Myeloma: From Immunopathogenesis to Novel Therapeutic Approaches, file e31e1250-8056-987f-e053-3705fe0a095a
|
21
|
|
COVID-19 severity and mortality in patients with chronic lymphocytic leukemia: a joint study by ERIC, the European Research Initiative on CLL, and CLL Campus, file e31e1250-8165-987f-e053-3705fe0a095a
|
19
|
|
Ibrutinib interferes with innate immunity in chronic lymphocytic leukemia patients during COVID-19 infection, file e31e1250-9a07-987f-e053-3705fe0a095a
|
18
|
|
Thrombotic and bleeding complications in patients with chronic lymphocytic leukemia and severe COVID-19: a study of ERIC, the European Research Initiative on CLL, file c7deba2e-55f9-42c2-9586-9484fa05cd22
|
17
|
|
Notch2 Increases the Resistance to Venetoclax-Induced Apoptosis in Chronic Lymphocytic Leukemia B Cells by Inducing Mcl-1, file e31e1250-a459-987f-e053-3705fe0a095a
|
15
|
|
How to improve prognostication in acute myeloid leukemia with cbfb‐myh11 fusion transcript: Focus on the role of molecular measurable residual disease (mrd) monitoring, file e31e1250-7cbd-987f-e053-3705fe0a095a
|
13
|
|
COVID-19 severity and mortality in patients with CLL: an update of the international ERIC and Campus CLL study, file e31e1250-a79c-987f-e053-3705fe0a095a
|
13
|
|
Validation and functional characterization of GWAS-identified variants for chronic lymphocytic leukemia: a CRuCIAL study, file 413f6d26-2a9d-4c6c-9f45-09256bd538c8
|
12
|
|
Relative dose intensity of obinutuzumab-chlorambucil in chronic lymphocytic leukemia: A multicenter Italian study, file 55f38af6-88c7-4d8a-91d1-c3536d342aad
|
12
|
|
BCR-ABL-specific T-cell therapy in Ph+ ALL patients on tyrosine-kinase inhibitors, file e31e1250-23c9-987f-e053-3705fe0a095a
|
11
|
|
PEG-Asparaginase Single-Agent Rescue in an Advanced Case of Monomorphic Epitheliotropic Intestinal T Cell Lymphoma, file e31e1250-895a-987f-e053-3705fe0a095a
|
11
|
|
Management of chronic lymphocytic leukemia in Italy during a one year of the COVID-19 pandemic and at the start of the vaccination program. A Campus CLL report, file e31e1250-a463-987f-e053-3705fe0a095a
|
10
|
|
Prognostic Relevance of Multi-Antigenic Myeloma-Specific T-Cell Assay in Patients with Monoclonal Gammopathies, file 0b85f648-0b8e-4b10-bf67-0fe675206cb0
|
9
|
|
Acute myeloid leukemia in patients living with HIV infection: Several questions, fewer answers, file e31e124e-6b35-987f-e053-3705fe0a095a
|
9
|
|
Role of Notch2 pathway in mature B cell malignancies, file 66834a4e-e34d-4559-85bd-6e279c213553
|
8
|
|
Clinical characteristics and outcome of west nile virus infection in patients with lymphoid neoplasms: An italian multicentre study, file e31e1250-7cc1-987f-e053-3705fe0a095a
|
8
|
|
Npm1‐mutated myeloid neoplasms with <20% blasts: A really distinct clinico‐pathologic entity?, file e31e1250-7075-987f-e053-3705fe0a095a
|
7
|
|
Bone marrow failure associated with human herpesvirus 8 infection after transplantation, file e31e124a-94c5-987f-e053-3705fe0a095a
|
6
|
|
Gestational thrombocytopenia [6] (multiple letters), file e31e1250-985c-987f-e053-3705fe0a095a
|
6
|
|
Early palliative care versus usual haematological care in multiple myeloma: retrospective cohort study, file 87808eec-8510-4fbe-9b8e-cfe94398dff4
|
5
|
|
Human herpesvirus-8 DNA sequences in Human Immunodeficiency Virus-negative angioimmunoblastic lymphadenopathy and benign lymphadenopathy with giant germinal center hyperplasia and increased vascularity, file e31e124a-9ebb-987f-e053-3705fe0a095a
|
4
|
|
Human Herpes virus-6 in human lymphomas: identification of specific sequences in Hodgkin's lymphomas by polymerase chain reaction, file e31e124c-8277-987f-e053-3705fe0a095a
|
4
|
|
Peripheral lymphadenopathy: role of excisional biopsy in differential diagnosis based on a five-year experience., file e31e124d-7b59-987f-e053-3705fe0a095a
|
4
|
|
Casein kinase 1: A new tale of chronic lymphocytic leukemia (CLL) microenvironment, file 244629fa-bbe3-4f95-bd5f-6de26bb1fc71
|
3
|
|
Chronic lymphocytic leukemia management in Italy during the COVID-19 pandemic: A Campus CLL report, file 966fd802-084b-4d83-9248-d0f2ed1f1c50
|
2
|
|
Antineoplastic effects of liposomal siRNA treatment targeting BLIMP1/PRDM1 in primary effusion lymphoma, file e31e124b-30fd-987f-e053-3705fe0a095a
|
2
|
|
DNA methylation-profiling identifies two splenic marginal zone lymphoma subgroups with different clinical and genetic features, file e31e124b-4f24-987f-e053-3705fe0a095a
|
2
|
|
The genetics of nodal marginal zone lymphoma, file e31e124b-cbf8-987f-e053-3705fe0a095a
|
2
|
|
Human herpesvirus 6 latently infects early bone marrow progenitors in vivo, file e31e124b-eb34-987f-e053-3705fe0a095a
|
2
|
|
Lenalidomide in chronic lymphocytic leukemia: The present and future in the era of tyrosine kinase inhibitors, file e31e124c-2998-987f-e053-3705fe0a095a
|
2
|
|
IRF4 modulates the response to BCR activation in chronic lymphocytic leukemia regulating IKAROS and SYK, file e31e1250-8aa4-987f-e053-3705fe0a095a
|
2
|
|
Adverse outcome associated with daratumumab-based treatments in relapsed/refractory multiple myeloma patients with amplification of chromosome arm 1q21: a single-center retrospective experience, file 1c9b129d-7def-4ad9-ab62-8d867abd1b98
|
1
|
|
Lack of confirmation of an association between HTLV-I infection and myelodysplastic syndrome, file e31e124a-9737-987f-e053-3705fe0a095a
|
1
|
|
Role of anti-hepatitis C virus (HCV) treatment in HCV-related, low-grade, B-cell, non-Hodgkin's lymphoma: a multicenter Italian experience, file e31e124a-9e79-987f-e053-3705fe0a095a
|
1
|
|
Strikingly homologous immunoglobulin gene rearrangements and poor outcome inV(H)3-21-using chronic lymphocytic leukemia patients independent of geographic origin and mutational status, file e31e124a-9fdd-987f-e053-3705fe0a095a
|
1
|
|
Aspirin, Warfarin, or Enoxaparin Thromboprophylaxis in Patients With Multiple Myeloma Treated With Thalidomide: A Phase III, Open-Label, Randomized Trial., file e31e124a-af0b-987f-e053-3705fe0a095a
|
1
|
|
Stereotyped B-cell receptor is an independent risk factor of chronic lymphocytic leukemia transformation to Richter syndrome., file e31e124a-b16a-987f-e053-3705fe0a095a
|
1
|
|
Angiopoietin-2 plasma dosage predicts time to first treatment and overall survival in chronic lymphocytic leukemia., file e31e124a-b16c-987f-e053-3705fe0a095a
|
1
|
| Totale |
8.809 |
